Arwa Al-Riyami Presents Key Findings: AI Use in Transfusion Medicine is Nascent but Growing in the EMNA Region
Arwa Al-Riyami, Senior Consultant Hematopathologist, Transfusion Medicine and Cellular Therapy at the University Medical City Oman, posted on LinkedIn:
“New publication: Artificial intelligence and big data in transfusion medicine: An exploratory assessment of status in the Eastern Mediterranean and North Africa (EMNA) region
Our regional survey gathered responses from transfusion medicine professionals including senior TM physicians and medical directors working in national or regional services, with over half affiliated to academic institutions.
Only 24% reported using AI in daily practice—mainly in the past two years and mostly for administrative tasks, education and research. Clinical use remains limited, though some apply AI in donor recruitment and management. Generative AI tools dominated (92%), and most users were self-taught. While 68% expect AI to have a significant impact on future TM practice, major barriers include lack of regulatory guidance, limited expertise, cost, IT limitations, and concerns around reliability, validation, ethics and privacy.
Big data is used in 36% of institutions, primarily for inventory forecasting, optimizing blood use and monitoring transfusion practices. Most rely on LIS data, donor databases and electronic health records. Key challenges include limited expertise in data management, insufficient storage infrastructure and difficulties integrating and analyzing large datasets.
These findings highlight strong interest but also substantial barriers in using AI and Big Data in the region. Advancing such innovations will require investment in regulation, workforce training and robust technical infrastructure.
Many thanks to all survey participants for sharing their valuable insights
For access here.”
Title: Use of artificial intelligence and big data in transfusion medicine: An exploratory assessment of status in the Eastern Mediterranean and North Africa region
Author: Arwa Al-Riyami, Suha Herjes

Get the latest on Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients